Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches

Table 4

Laboratory assays in the study group, depending on the line of disease-modifying therapy.

	LI	LII
	[µM]				0.003
IL-1β/IL- [pg/mL]			0.81
[mg/L]			0.06

A: nitric oxide (nitrite and nitrate); b: interleukin; c: C-reactive protein.